In situ hybridization for human papillomavirus DNA in squamous cell carcinomas of the larynx and inverted papillomas

Polish Journal of Pathology

Volumn 61, Issue 1, 2010, Pages 32-36

  Stasikowska Kanicka, Olga ^a   Danilewicz, Marian ^a   Wagrowska Danilewicz, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Human papillomavirus; Inverted papilloma; Laryngeal cancer

Indexed keywords

VIRUS DNA;

GENETICS; HUMAN; IN SITU HYBRIDIZATION; INVERTED PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION;

DNA, VIRAL; HUMANS; IN SITU HYBRIDIZATION; PAPILLOMA, INVERTED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION;

EID: 78650210051     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kim ES, Kies M, Herbst RS. Novel therapeutics for head and neck cancer. Curr Opin Oncol 2002; 14: 334-342.
2. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32: 59-66.
3. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-1131.
4. Chocolatewala NM, Chaturvedi P. Role of human papilloma virus in the oral carcinogenesis: an Indian perspective. J Cancer Res Ther 2009; 5: 71-77.
5. Burk RD, Chen Z, Van Doorslaer K. Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics 2009; 12: 281-290.
6. Lehoux M, D'Abramo CM, Archambault J. Molecular mechanisms of human papillomavirus-induced carcino genesis. Public Health Genomics 2009; 12: 268-280.
7. IARC 1995. Monographs on the evaluation of carcinogenic risks to human. Papillomaviruses (www.inchem.org/documents/iarc/vol64/hpv.html)
8. Major T, Szarka K, Sziklai I, et al. The characteristic of human papillomavirus DNA in head and neck cancer and papillomas. J Clin Pathol 2005; 58: 51-55.
9. Slebos RJ, Yi Y, Ely K, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006; 12 (3 Pt 1): 701-709.
10. Neufcoeur PE, Arafa M, Delvenne P, et al. Involvement of human papillomavirus in upper aero-digestive tracts cancers. Bull Cancer 2009; 96: 941-950 (abstract).
11. Bosch FX, Lorincz A, Muñoz N, et al. The casual relation between human papilomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
12. Hsueh PR. Human papillomavirus, genital warts, and vaccines. J Microbiol Immunol Infect 2009; 42: 101-106.
13. Brandwein M, Steinberg B, Thung S, et al. Human papillomavirus 6/11 and 16/18 in schneiderian inverted papillomas, In situ hybridization with human papillomaviruses RNA probes. Cancer 1989; 63: 1708-1713.
14. Zhou Y, Hu M, Li Z. Human papillomavirus (HPV) and DNA test in inverted papillomas of the nasal cavities and paranasal sinuses. Zhonghua Er Bi Yan Hou Ke Za Zhi 1997; 32: 345-347 (abstract).
15. Kashima HK, Kessis T, Hruban RH, et al. Human papillomavirus in sinonasal papillomas and squamous cell carcinoma. Laryngoscope 1992; 102: 973-976.
16. Batsakis JG, Suares P. Schneiderian papillomas and carcinomas: a review. Adv Anat Pathol 2001; 8: 53-64.
17. Krawczyk E, Suprynowicz FA, Liu X, et al. Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am J Pathol 2008; 173: 682-688.
18. Barnes L, Everson JW, Reichart P, et al. World Health Organization Classification of Tumours. Pathology and Genetics Head and Neck Tumours. IARC Press, Lyon 2005; 26-32, 118-121.
19. Lu SS, Zou R, Xu JW. Relationship between prognosis of nasal inverted papilloma and human papillomavirus types. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2005; 40: 195-198 (abstract).
20. McKay SP, Grégoire L, Lonardo F, et al. Human papillomavirus (HPV) transcripts in malignant inverted papilloma are from integrated HPV DNA. Laryngoscope 2005; 115: 1428-1431.
21. Kim JY, Yoon JK, Citardi MJ, et al. The prevalence of human papilloma virus infection in sinonasal inverted papilloma specimens classified by histological grade. Am J Rhinol 2007; 21: 664-669.
22. Guan Y, Zang C, Zhang C. Study on correlation between HPV57 infection and the etiology of IP. Lin. Chuang Er Bi Yan Hou Ke Za Zhi 2006; 20: 922-924, 927 (abstract).
23. Hartley C, Hamilton J, Birzgalis AR, et al. Recurrent respiratory papillomatosis - the Manchester experience, 1974-1992. J Laryngol Otol 1994; 108: 226-229.
24. Syrjänen S. Human Papillomaviruses in Head and Neck Carcinomas. N Engl J Med 2007; 357: 313.
25. Al Moustafa AE, Kassab A, Darnel A, et al. High-risk HPV/ErbB-2 interaction on E-cadherin/catenin regulation in human carcinogenesis. Curr Pharm Des 2008; 14: 2159-2172.